Pediatric Acetaminophen Expanded Dosing Requested In McNeil Petition
This article was originally published in The Tan Sheet
Executive Summary
Expanded dosing directions in the labeling of pediatric acetaminophen products to include children under two is requested by McNeil Consumer Healthcare in a citizen petition filed with FDA Feb. 1.
You may also be interested in...
CHPA Agenda 2014: Monograph Reform, NSURE Progress
The Consumer Healthcare Products Association plans to tackle big tasks in 2014, including working with FDA to improve the monograph system, move the new Rx-to-OTC switch paradigm forward and determine quality metrics to help FDA better target inspections. The trade group also is looking for ways to ease pricing pressures and ensure quality does not suffer.
CHPA Agenda 2014: Monograph Reform, NSURE Progress
The Consumer Healthcare Products Association plans to tackle big tasks in 2014, including working with FDA to improve the monograph system, move the new Rx-to-OTC switch paradigm forward and determine quality metrics to help FDA better target inspections. The trade group also is looking for ways to ease pricing pressures and ensure quality does not suffer.
CHPA Petitions For Acetaminophen Under-2 Dose Labeling
CHPA urges FDA not to wait until it publishes the final internal analgesics, antipyretic and anti-rheumatic monograph before allowing manufacturers to label acetaminophen products with dosing information for children 6 months to 2 years old. In a citizen petition, the trade group proposes FDA publish a statement of enforcement policy expressly permitting the use of a standardized age- and weigh-based dosing chart.